Use of Oral Anticoagulation in Patients With Atrial Fibrillation and End-stage Renal Disease: What Is Needed Nowadays? Response

被引：0
|
作者：
Mahmood, Maria [1 ]
Lip, Gregory Y. H. [1 ,2 ]
机构：
[1] Univ Birmingham, Inst Cardiovasc Sci, Birmingham, W Midlands, England
[2] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark
来源：
REVISTA ESPANOLA DE CARDIOLOGIA | 2019年 / 72卷 / 01期
关键词：
STROKE; OUTCOMES;
D O I：
10.1016/j.recesp.2018.07.023
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：97 / 98
页数：2
相关论文
共 50 条
  • [1] Use of Oral Anticoagulation for Patients With Atrial Fibrillation and End-stage Renal Disease: What Is Needed Nowadays?
    Li, Jun
    Liu, Xinyue
    Zheng, Sulin
    Huang, Yuli
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2019, 72 (01): : 96 - 97
  • [2] Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease
    Pokorney, Sean D.
    Black-Maier, Eric
    Hellkamp, Anne S.
    Friedman, Daniel J.
    Vemulapalli, Sreekanth
    Granger, Christopher B.
    Thomas, Laine
    Peterson, Eric D.
    Piccini, Jonathan P., Sr.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1299 - 1308
  • [3] Reply: Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease
    Pokorney, Sean D.
    Black-Maier, Eric
    Piccini, Jonathan P.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (03) : 351 - 352
  • [4] Oral Anticoagulation in Patients With End-Stage Kidney Disease on Dialysis and Atrial Fibrillation
    Hu, Austin
    Niu, Jingbo
    Winkelmayer, Wolfgang C.
    [J]. SEMINARS IN NEPHROLOGY, 2018, 38 (06) : 618 - 628
  • [5] Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal Disease
    Zaman, Junaid A. B.
    Bhandari, Anil K.
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2019, 24 (06) : 499 - 508
  • [6] Oral anticoagulation in end-stage renal disease and atrial fibrillation: is it time to just say no to drugs?
    Black-Maier, Eric
    Piccini, Jonathan P.
    [J]. HEART, 2017, 103 (11) : 807 - 808
  • [7] Anticoagulation in Patients with End-Stage Renal Disease and Atrial Fibrillation: Confusion, Concerns and Consequences
    Goel, Narender
    Jain, Deepika
    Haddad, Danny B.
    Shanbhogue, Divya
    [J]. JOURNAL OF STROKE, 2020, 22 (03) : 306 - 316
  • [8] Anticoagulation for Patients With Atrial Fibrillation and End-Stage Renal Disease on Dialysis: A National Survey
    Halperin, Laura F.
    Lee, May K.
    Liew, Janet
    Lauck, Sandra
    Kong, Darren
    Krahn, Andrew D.
    Deyell, Marc W.
    Andrade, Jason G.
    Hawkins, Nathaniel M.
    Chakrabarti, Santabhanu
    Yeung-Lai-Wah, Ah Fan John
    Bennett, Matthew T.
    Cheung, Christopher
    Levin, Adeera
    Schwartz, Daniel I.
    Laksman, Zachary W.
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2021, 37 (06) : 924 - 928
  • [9] Atrial fibrillation in patients with end-stage renal disease on hemodialysis: Magnitude of the problem and new approach to oral anticoagulation
    Koenigsbruegge, Oliver
    Ay, Cihan
    [J]. RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2019, 3 (04) : 578 - 588
  • [10] Atrial fibrillation in end-stage renal disease
    Korantzopoulos, Panagiotis
    Kokkoris, Stelios
    Liu, Tong
    Protopsaltis, Ioannis
    Li, Guangping
    Goudevenos, John A.
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2007, 30 (11): : 1391 - 1397
12345